期刊文献+

药物经济学评价系统的开发与应用 被引量:2

Development and Application of Evaluation System of Pharmacoeconomics
原文传递
导出
摘要 目的:开发一套应用简便、实用的药物经济学评价系统。方法:利用SQL Server2000建立数据库,以Delphi语言为编程工具,进行药物经济学评价系统的开发。结果:本系统具有良好的人机交互界面,包括数据录入、成本-效果、成本-效益和成本-效用分析结果界面,其中敏感度分析结果包括了单纯法、Bootstrap法和排序稳定性分析法的计算结果。结论:本系统操作简便,结果可靠,值得推广。 OBJECTIVE:To develop a simple but practical evaluation system of pharmacoeconomics.METHODS:The data base of this system was built up using the SQL Server 2000.Delphi was used as programming tool to develop an evaluation system of pharmacoeconomics .RESULTS: This system has good human- computer interfaces, including the interfaces of data input, cost- effectiveness analysis, cost- benefit analysis and costutility analysis .The sensitivity analytic results consisted of the computed results of simple analysis, bootstrap analysis and rankorder stability analysis.CONCLUSION: System testing indicates the system is simple in operation and reliable in analytical results,which thus deserves to be popularized.
机构地区 青岛市市立医院
出处 《中国药房》 CAS CSCD 北大核心 2008年第2期81-83,共3页 China Pharmacy
关键词 药物经济学 评价系统 开发 应用 Pharmacoeconomics Evaluation system Development Application
  • 相关文献

参考文献7

二级参考文献8

共引文献5

同被引文献40

  • 1吴晶,孙利华,刘国恩.中国药物经济学学科发展现状[J].中国药物经济学,2008,0(6):29-36. 被引量:13
  • 2Grieve R, Cairns J Thompson, S G Thompson. Improving costing methods in multicentre economic evaluation: the use of multiple imputation for unit costs [J].Health Economics, 2010,19(8):939-5.
  • 3Meerding J W, Bonsel J G, Brouwer F B W, Stuifbergen C M, Essink-Bot L M.Social Time Preferences for Health and Money Elicited with a Choice Experiment. Value in Health, 2010, 13(3):368-374.
  • 4Wright D R, Wittenberg E, Swan J S, Miksad RA, Prosser LA. Methods for Measuring Temporary Health States for Cost-Utility Analyses[J]. Pharmacoeconomics, 2009,27(9):713-23.
  • 5Peeters Y, Stlggelbout M A. Health State Valuations of Patients and the General Public. Analytically Compared A Meta-analytical Comparison fo Patient and Population Health State Utilities. Value in Health, 2010,13(2): 306-309.
  • 6Happlch M, Moock J, Lengerke v T. Health State Valuation Methods and Reference Points: The Case of Tinnitus. Value in Health, 2009,12(1): 88-95.
  • 7Seymour J, McNamee P, Scott A, Tinelli M. Shedding new Light onto the ceiling and floor? A quantile regression approach to compare EQ-5D and SF-6D responses. Health Econ, 2010,19: 683-696.
  • 8Ferrelra N L, Ferrelra L P, Perelra N L. A Portuguese Value Set for the SF-6D. Value in Health, 2010,13(5): 624-630.
  • 9Perneger V T, Combescure C, Courvolsler S D. General Population Reference Values for the French Version of the EuroQol EQ-5D Health Utility Instrument. Value in Health, 2010,13(5): 631-635.
  • 10Sharma R, Stano M.Implications of an economic model of health states worse than dead. Journal of Health Economics, 2010, 29(4):536-540.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部